You have 9 free searches left this month | for more free features.

uterine leiomyosarcoma

Showing 1 - 25 of 1,897

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Uterine Leiomyosarcoma Trial (Letrozole)

Not yet recruiting
  • Uterine Leiomyosarcoma
  • (no location specified)
Dec 6, 2022

Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York

Recruiting
  • Locally Advanced Leiomyosarcoma
  • +5 more
  • New York, New York
    Columbia University/Herbert Irving Cancer Center
Jan 4, 2023

LMS - Leiomyosarcoma, Uterine Leiomyosarcoma Trial in Stanford (drug, procedure, behavioral)

Suspended
  • LMS - Leiomyosarcoma
  • Uterine Leiomyosarcoma
  • Stanford, California
    Stanford University
Oct 24, 2022

Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York

Not yet recruiting
  • Locally Advanced Leiomyosarcoma
  • +8 more
  • (no location specified)
Jul 6, 2022

Metastatic Leiomyosarcoma, Unresectable Leiomyosarcoma, Uterine Corpus Leiomyosarcoma Trial in Boston (Ipilimumab, Laboratory

Active, not recruiting
  • Metastatic Leiomyosarcoma
  • +2 more
  • Ipilimumab
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2022

Stage III Uterine Corpus Leiomyosarcoma AJCC v8, Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 Trial in United States (Computed

Active, not recruiting
  • Stage III Uterine Corpus Leiomyosarcoma AJCC v8
  • Stage IV Uterine Corpus Leiomyosarcoma AJCC v8
  • Computed Tomography
  • +4 more
  • Phoenix, Arizona
  • +14 more
Aug 23, 2022

Uterine or Soft Tissue Leiomyosarcoma Trial in Villejuif (Doxorubicin, Trabectedin)

Completed
  • Uterine or Soft Tissue Leiomyosarcoma
  • Villejuif, Val De Marne, France
    Gustave Roussy
Dec 10, 2021

Metastatic Leiomyosarcoma, Metastatic Soft Tissue Sarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in United

Recruiting
  • Metastatic Leiomyosarcoma
  • +10 more
  • Duarte, California
  • +4 more
Nov 4, 2021

Uterine Cancer, Endometrial Carcinoma, Carcinosarcoma Trial in United States (Nivolumab)

Active, not recruiting
  • Uterine Cancer
  • +6 more
  • Basking Ridge, New Jersey
  • +7 more
Apr 4, 2022

Early Differential Diagnosis of Uterine Leiomyomas and

Recruiting
  • Leiomyoma
  • Leiomyosarcoma
  • Biopsy and peripheral blood collection
  • Cartagena, Murcia, Spain
  • +3 more
Sep 2, 2021

Preoperative Molecular Diagnosis of Uterine Tumors by Liquid

Recruiting
  • Leiomyoma, Uterine
  • Leiomyosarcoma Uterus
  • Collection of Leiomyoma samples
  • +2 more
  • LĀ“Hospitalet de Llobregat, Barcelona, Spain
  • +20 more
Sep 2, 2021

Leiomyosarcoma, Endometrial Stromal Tumors, Carcinosarcomas Uterine Trial in Graz (Vorinostat Oral Capsule)

Terminated
  • Leiomyosarcoma
  • +2 more
  • Vorinostat Oral Capsule
  • Graz, Austria
    Medical University of Graz, Clinic of Obstetrics and Gynecology
Jul 27, 2020

Molecular Mechanism Study of Uterine Sarcoma

Recruiting
  • Uterine Sarcoma
  • Diagnostic biomarker
  • Wuhan, Hubei, China
    Yan Li
May 21, 2023

Leiomyosarcoma or Carcinosarcoma Trial in Germany (Pazopanib plus Gemcitabine, Pazopanib)

Recruiting
  • Leiomyosarcoma or Carcinosarcoma
  • Bad Saarow, Germany
  • +8 more
Nov 27, 2020

Stage IA Uterine Sarcoma, Stage IB Uterine Sarcoma, Stage IC Uterine Sarcoma Trial in Bronx (drug, radiation, other)

Terminated
  • Stage IA Uterine Sarcoma
  • +10 more
  • Gemcitabine Hydrochloride
  • +5 more
  • Bronx, New York
    Albert Einstein College of Medicine
Dec 10, 2019

Soft Tissue Sarcoma Trial (ADI PEG20, Placebo)

Not yet recruiting
  • Soft Tissue Sarcoma
  • ADI PEG20
  • Placebo
  • (no location specified)
Jan 31, 2023

Leiomyosarcoma Trial in Beijing (Temozolomide for injection combined with epirubicin)

Recruiting
  • Leiomyosarcoma
  • Temozolomide for injection combined with epirubicin
  • Beijing, Beijing, China
    Cancer Hospital of Chinese Academy of Medical Sciences
Jan 11, 2022

Leiomyosarcoma Trial in France (pazopanib + gemcitabine)

Completed
  • Leiomyosarcoma
  • pazopanib + gemcitabine
  • Bordeaux, France
  • +16 more
Jan 29, 2020

Leiomyosarcoma of Ovary, Soft Tissue Sarcoma Trial in Italy (Trabectedin, Gemcitabine, No Intervention: Observational Cohort)

Active, not recruiting
  • Leiomyosarcoma of Ovary
  • Soft Tissue Sarcoma
  • Bologna, BO, Italy
  • +12 more
Oct 29, 2021

Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma Trial in Philadelphia (Thalidomide, Laboratory Biomarker

Completed
  • Recurrent Uterine Corpus Sarcoma
  • Uterine Corpus Leiomyosarcoma
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Leiomyosarcoma, Uterine Tumor Trial in Houston (Letrozole)

Terminated
  • Leiomyosarcoma
  • Uterine Neoplasm
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 23, 2018

Recurrent Uterine Corpus Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma Trial in United States (biological,

Terminated
  • Recurrent Uterine Corpus Sarcoma
  • +6 more
  • Bevacizumab
  • +5 more
  • Phoenix, Arizona
  • +200 more
Aug 20, 2020

Glabellar Frown Lines Trial in Canada, United States (Botulinum Toxins, Type A, Placebos)

Completed
  • Glabellar Frown Lines
  • Botulinum Toxins, Type A
  • Placebos
  • Encinitas, California
  • +13 more
Jun 29, 2022

Leiomyoma Trial in Ottawa (Supersonic Imagine Aixplorer SWE Ultrasound Imaging)

Enrolling by invitation
  • Leiomyoma
  • Supersonic Imagine Aixplorer SWE Ultrasound Imaging
  • Ottawa, Ontario, Canada
    University of Ottawa, Motor Function Measurement Laboratory
Jun 8, 2022